BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19032135)

  • 1. Comparison of efficacy and safety of ciprofloxacin otic solution 0.2% versus polymyxin B-neomycin-hydrocortisone in the treatment of acute diffuse otitis externa*.
    Drehobl M; Guerrero JL; Lacarte PR; Goldstein G; Mata FS; Luber S
    Curr Med Res Opin; 2008 Dec; 24(12):3531-42. PubMed ID: 19032135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
    Rahman A; Rizwan S; Waycaster C; Wall GM
    Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
    Schwartz RH
    Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa.
    Roland PS; Pien FD; Schultz CC; Henry DC; Conroy PJ; Wall GM; Garadi R; Dupre SJ; Potts SL; Hogg LG; Stroman DW;
    Curr Med Res Opin; 2004 Aug; 20(8):1175-83. PubMed ID: 15324520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single topical agent is clinically equivalent to the combination of topical and oral antibiotic treatment for otitis externa.
    Roland PS; Belcher BP; Bettis R; Makabale RL; Conroy PJ; Wall GM; Dupre S; Potts S; Hogg G; Weber K;
    Am J Otolaryngol; 2008; 29(4):255-61. PubMed ID: 18598837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ofloxacin otic solution for treatment of otitis externa in children and adults.
    Jones RN; Milazzo J; Seidlin M
    Arch Otolaryngol Head Neck Surg; 1997 Nov; 123(11):1193-200. PubMed ID: 9366699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Ciprofloxacin Plus Fluocinolone Acetonide Among Patients With Acute Otitis Externa: A Randomized Clinical Trial.
    Chu L; Acosta AM; Aazami H; Dennis P; De Valle O; Ehmer D; Hedrick JA; Ansley JF
    JAMA Netw Open; 2022 Jul; 5(7):e2221699. PubMed ID: 35834251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled multicenter study on chronic suppurative otitis media treated with topical applications of ciprofloxacin 0.2% solution in single-dose containers or combination of polymyxin B, neomycin, and hydrocortisone suspension.
    Miró N
    Otolaryngol Head Neck Surg; 2000 Nov; 123(5):617-23. PubMed ID: 11077352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in bacteriologic treatment failures in acute otitis externa between ciprofloxacin/dexamethasone and neomycin/polymyxin B/hydrocortisone: results of a combined analysis.
    Dohar JE; Roland P; Wall GM; McLean C; Stroman DW
    Curr Med Res Opin; 2009 Feb; 25(2):287-91. PubMed ID: 19192973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Declining susceptibility to neomycin and polymyxin B of pathogens recovered in otitis externa clinical trials.
    Cantrell HF; Lombardy EE; Duncanson FP; Katz E; Barone JS
    South Med J; 2004 May; 97(5):465-71. PubMed ID: 15180022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes.
    Dohar J; Giles W; Roland P; Bikhazi N; Carroll S; Moe R; Reese B; Dupre S; Wall M; Stroman D; McLean C; Crenshaw K
    Pediatrics; 2006 Sep; 118(3):e561-9. PubMed ID: 16880248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of safety and efficacy of foam-based versus solution-based ciprofloxacin for acute otitis externa.
    Marom T; Yelin R; Goldfarb A; Rakover Y; Shlizerman L; Eilat E; Roth Y
    Otolaryngol Head Neck Surg; 2010 Oct; 143(4):492-9. PubMed ID: 20869557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes.
    Roland PS; Kreisler LS; Reese B; Anon JB; Lanier B; Conroy PJ; Wall GM; Dupre SJ; Potts S; Hogg G; Stroman DW; McLean C
    Pediatrics; 2004 Jan; 113(1 Pt 1):e40-6. PubMed ID: 14702493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Otitis externa: clinical comparison of local ciprofloxacin versus local oxytetracycline, polymyxin B, hydrocortisone combination treatment.
    Arnes E; Dibb WL
    Curr Med Res Opin; 1993; 13(3):182-6. PubMed ID: 8222746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciprofloxacin otic suspension (Otiprio) for acute otitis externa.
    Med Lett Drugs Ther; 2018 Aug; 60(1553):135-136. PubMed ID: 30133425
    [No Abstract]   [Full Text] [Related]  

  • 16. A group III steroid solution without antibiotic components: an effective cure for external otitis.
    Emgård P; Hellström S
    J Laryngol Otol; 2005 May; 119(5):342-7. PubMed ID: 15949095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of ofloxacin otic solution once daily for 7 days in the treatment of otitis externa: a multicenter, open-label, phase III trial.
    Torum B; Block SL; Avila H; Montiel F; Oliva A; Quintanilla W; Duncanson F; Cantrell HF; Riefler J; Katz E; Lombardy E
    Clin Ther; 2004 Jul; 26(7):1046-54. PubMed ID: 15336469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of cortisporin and ciprofloxacin otic drops as prophylaxis against post-tympanostomy otorrhea.
    Morpeth JF; Bent JP; Watson T
    Int J Pediatr Otorhinolaryngol; 2001 Nov; 61(2):99-104. PubMed ID: 11589975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of the synergistic activity of neomycin-polymyxin B association against pathogens responsible for otitis externa.
    Tempera G; Mangiafico A; Genovese C; Giudice E; Mastrojeni S; Nicolosi D; Ferneri PM
    Int J Immunopathol Pharmacol; 2009; 22(2):299-302. PubMed ID: 19505383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relation of patient satisfaction with treatment of otitis externa to clinical outcomes: development of an instrument.
    Shikiar R; Halpern MT; McGann M; Palmer CS; Seidlin M
    Clin Ther; 1999 Jun; 21(6):1091-104. PubMed ID: 10440629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.